We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current EDSA market cap is 7.11M. The company's latest EPS is USD -1.9000 and P/E is -1.15.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.86M | -2.22M | -1.93M | -1.01M | -1.9M |
| Net Income | -1.68M | -1.86M | -1.67M | -962k | -1.62M |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 329k | 0 | 0 | 0 | 0 |
| Operating Income | -6.4M | -23.68M | -18.37M | -9.22M | -7.02M |
| Net Income | -6.36M | -13.34M | -17.55M | -8.37M | -6.17M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.83M | 6.48M | 5.23M | 3.81M | 4.16M |
| Total Liabilities | 1.99M | 2.15M | 2.36M | 1.83M | 1.9M |
| Total Equity | 5.85M | 4.32M | 2.87M | 1.98M | 2.26M |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.76M | 14.58M | 11.58M | 8.89M | 3.81M |
| Total Liabilities | 4.13M | 1.53M | 2.18M | 1.84M | 1.83M |
| Total Equity | 6.63M | 13.06M | 9.39M | 7.05M | 1.98M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.41M | -3.07M | -3.92M | -4.89M | -1.52M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 306k | 518k | 624k | 592k | 2.07M |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.99M | -13.66M | -12.28M | -6.64M | -4.89M |
| Investing | 19k | -6k | -5k | N/A | N/A |
| Financing | 7.09M | 14.18M | 11.63M | 4.83M | 592k |
| Market Cap | 7.11M |
| Price to Earnings Ratio | -1.15 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.86 |
| Price to Book Ratio | 3.59 |
| Dividend Yield | - |
| Shares Outstanding | 3.25M |
| Average Volume (1 week) | 74.72k |
| Average Volume (1 Month) | 6.19M |
| 52 Week Change | -57.72% |
| 52 Week High | 5.59 |
| 52 Week Low | 1.55 |
| Spread (Intraday) | 0.98 (35.9%) |
| Company Name | Edesa Biotech Inc |
| Address |
100 spy court markham, ontario L3R 5H6 |
| Website | https://www.edesabiotech.com |
| Industry | business services, nec (7389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
